Taken together, our study provides new knowledge about the prevalence and clinical significance of MYB and MYBL1 alterations in ACC and indicates the presence of genes with tumor suppressive functions in 6q23.3-qter that contribute to poor prognosis in a subset of tumors. Here, MYB is linked to adrenal cortex carcinoma.